title: Engineering of erythrocyte-based drug carriers: control of protein release and bioactivity.
abstract: This work reports the fabrication of layer-by-layer (LbL) polyelectrolyte coated erythrocyte carriers that provide a simple means for controlling the burst and subsequent release of lysozyme. Erythrocytes were loaded with RITC-lysozyme as model compound via the hypotonic dialysis method. An encapsulation efficiency of 41.6% and a loading amount of 12.7 pg/cell was achieved. It is demonstrated that these carriers maintain their shape and integrity similar to natural erythrocytes after the encapsulation procedures, and achieve a uniform distribution of the encapsulated lysozyme. The erythrocyte carriers were fixed with glutaraldehyde and then successfully coated with biocompatible polyelectrolytes, poly-L: -lysine hydrobromide and dextran sulfate, using the LbL method. It is demonstrated that the release profile of the encapsulated macromolecule can be regulated by adjusting the number of polyelectrolyte layers. Furthermore by adjusting the concentrations of the cross linking agent the activity of the encapsulated lysozyme can be well preserved. These core-shell microcapsules, consisting of erythrocytes loaded with bioactive substances and coated with a polyelectrolyte multilayer shell, hold promise for a new type of biocompatible and biodegradable drug delivery system.
authors.affiliation: School of Materials Science and Engineering, Nanyang Technological University, Singapore, Singapore.
authors.forename: Rongcong
authors.initials: R
authors.lastname: Luo
authors.forename: Shaillender
authors.initials: S
authors.lastname: Mutukumaraswamy
authors.forename: Subbu S
authors.initials: SS
authors.lastname: Venkatraman
authors.forename: Björn
authors.initials: B
authors.lastname: Neu
mesh_terms: D001672:Biocompatible Materials; D004337:Drug Carriers; D004912:Erythrocytes; D006801:Humans; D009113:Muramidase / Q000008:administration & dosage* / Q000494:pharmacology
chemical_list: D001672:Biocompatible Materials; D004337:Drug Carriers; D009113:Muramidase
references.citation: J Control Release. 2007 Apr 2;118(2):145-60
references.pmid: 17270305
references.citation: Blood. 1981 May;57(5):866-72
references.pmid: 7214016
references.citation: Science. 2003 Apr 25;300(5619):615-8
references.pmid: 12714738
references.citation: Biomaterials. 2009 Feb;30(5):959-67
references.pmid: 19027156
references.citation: Nature. 1978 Mar 16;272(5650):258-60
references.pmid: 628451
references.citation: Drug Deliv. 2003 Jan-Mar;10(1):9-20
references.pmid: 12554359
references.citation: Langmuir. 2009 Sep 1;25(17):10020-5
references.pmid: 19705896
references.citation: Mol Pharm. 2006 Mar-Apr;3(2):135-43
references.pmid: 16579642
references.citation: J Microencapsul. 1992 Jul-Sep;9(3):357-64
references.pmid: 1403486
references.citation: Int J Pharm. 2007 Jun 29;338(1-2):70-8
references.pmid: 17317049
references.citation: Drug Deliv. 2001 Oct-Dec;8(4):223-30
references.pmid: 11757780
references.citation: Biomaterials. 2003 Mar;24(7):1121-31
references.pmid: 12527253
references.citation: Adv Drug Deliv Rev. 2008 Jun 30;60(10):1167-76
references.pmid: 18479776
references.citation: Vaccine. 2010 Apr 9;28(17):2965-72
references.pmid: 20188177
references.citation: Biomaterials. 2009 Feb;30(4):682-9
references.pmid: 19000635
references.citation: Nano Lett. 2011 May 11;11(5):2152-6
references.pmid: 21486057
references.citation: J Control Release. 2000 Jul 31;68(1):41-52
references.pmid: 10884578
references.citation: Angew Chem Int Ed Engl. 2004 Jul 19;43(29):3762-83
references.pmid: 15258935
references.citation: Int J Pharm. 2010 Nov 30;401(1-2):41-6
references.pmid: 20854886
references.citation: J Pharm Pharm Sci. 2011;14(1):46-59
references.pmid: 21501552
references.citation: J Microencapsul. 2001 May-Jun;18(3):385-95
references.pmid: 11308228
references.citation: Blood Cells Mol Dis. 2004 Sep-Oct;33(2):132-40
references.pmid: 15315791
references.citation: Adv Drug Deliv Rev. 2008 Jan 14;60(2):286-95
references.pmid: 17997501
references.citation: Biomacromolecules. 2003 Mar-Apr;4(2):265-72
references.pmid: 12625721
references.citation: Int J Pharm. 2011 Aug 30;415(1-2):211-7
references.pmid: 21699968
references.citation: Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):10980-5
references.pmid: 21690347
references.citation: Science. 2003 Apr 25;300(5619):595-6
references.pmid: 12714733
references.citation: Biomaterials. 2008 Nov;29(31):4195-204
references.pmid: 18691753
references.citation: Int J Pharm. 2007 Aug 16;341(1-2):125-33
references.pmid: 17512685
references.citation: Biochim Biophys Acta. 1977 Feb 28;496(2):507-15
references.pmid: 402162
references.citation: Biotechnol Appl Biochem. 1990 Dec;12(6):621-9
references.pmid: 2128736
references.citation: Science. 1998 Nov 6;282(5391):1111-4
references.pmid: 9804547
references.citation: Blood. 2006 Dec 1;108(12):3637-45
references.pmid: 16882712